BK-VP3 as a new target of cellular immunity in BK virus infection. 2011

Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
Department of Nephrology, Charite University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany.

BACKGROUND Polyomavirus BK virus (BKV) infection represents a serious complication leading to BKV-associated nephropathy (BKVAN) and subsequent kidney graft loss in up to 10% of transplant patients. Cellular immunity is known to play a crucial role in the control of BKV replication. However, the knowledge on the BKV-T-cell response is limited: only two (VP1 and large T antigen) of six known BKV proteins were evaluated for their antigenicity so far. METHODS By using 10-color flow cytometry and newly created overlapping peptide pools of five BKV antigens (VP1, VP2, VP3, large T antigen, and small t antigen), we performed cross-sectional phenotypic and functional analysis of BKV-specific T cells in kidney transplant patients with a history of BKVAN. Patients with clinically unapparent BKV infection (history of transient/no BKV reactivation) were used as control group. RESULTS Our data demonstrate for the first time the antigenic properties of all five evaluated proteins with VP3 as a new important target of cellular immunity. Further, we found a correlation between the severity of the previous BKV infection and the magnitude of memory CD4+ T-cell response. Thus, compared with the control group, patients with a history of BKVAN demonstrated significantly higher frequencies of interferon-γ- and interleukin-2-producing effector memory CD4+ T cells. In the control group, more patients with detectable interferon-γ+/interleukin-2+/tumor necrosis factor+ triple producers were found, suggesting possibly a protective function of these multifunctional T cells. CONCLUSIONS In conclusion, our study results suggest an implementation of new targets for monitoring of BKV immunity. Further studies are required to evaluate the protective function of the found BKV-specific T-cell subsets.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001739 BK Virus A species of POLYOMAVIRUS apparently infecting over 90% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances. BK polyomavirus,Human Polyomavirus BK,Polyomavirus, BK,Polyomavirus hominis 1,Polyomavirus BK, Human
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
January 2015, Frontiers in immunology,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
May 2004, Journal of virology,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
March 1980, Acta virologica,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
February 2021, Journal of virology,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
January 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
January 1989, Advances in experimental medicine and biology,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
October 1993, Bulletin de l'Academie nationale de medecine,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
January 2000, The American journal of surgical pathology,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
December 2010, Transplantation,
Karin Mueller, and Thomas Schachtner, and Arne Sattler, and Sarah Meier, and Peter Friedrich, and Hanna Trydzenskaya, and Carl Hinrichs, and Ralf Trappe, and Andreas Thiel, and Petra Reinke, and Nina Babel
January 2006, Viral immunology,
Copied contents to your clipboard!